Literature DB >> 1630595

Toxic effects of solstitialin A 13-acetate and cynaropicrin from Centaurea solstitialis L. (Asteraceae) in cell cultures of foetal rat brain.

C H Cheng1, B Costall, M Hamburger, K Hostettmann, R J Naylor, Y Wang, P Jenner.   

Abstract

Extracts of the aerial parts of the yellow star thistle (Centaurea solstitialis L.) were prepared using petroleum ether, chloroform and methanol and toxicity assessed in primary cell cultures of striatum, frontal cortex and mesencephalon, containing the substantia nigra or raphe nucleus from the brain of the foetal rat. Chloroform extracts significantly reduced the percentage of live cells whereas the petroleum ether extract was inactive. The ability of the methanol extract to reduce the percentage of live cells could not be distinguished from the effects of the vehicle controls for methanol. Subsequently, the plant material was extracted with dichloromethane and 10 fractions were obtained by column chromatography. Fractions 5, 6, 7 and 8 caused concentration-dependent cell death in the culture of substantia nigra, the other fractions were not toxic at the concentrations used. In further studies, solstitialin A was isolated from fraction 9, solstitialin A 13-acetate from fraction 6 and solstitialin A-3 acetate and cynaropicrin from fraction 7. Solstitialin A 13-acetate and cynaropicrin were toxic to cultures of substantia nigra cells. It is concluded that, of the compounds identified, solstitialin A 13-acetate and cynaropicrin have toxic potential in cell cultures, containing cells from the substantia nigra of the rat, the specificity of action to cells of the substantia nigra remains to be shown, and that a toxic action in the midbrain may contribute to the nigro-pallidal encephalomalacia, caused by the ingestion of the yellow star thistle by horses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1630595     DOI: 10.1016/0028-3908(92)90177-q

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  The effect of dehydroleucodine in adipocyte differentiation.

Authors:  Adriana Galvis; Adriana Marcano; Chad Stefancin; Nicole Villaverde; Horacio A Priestap; Carlos E Tonn; Luis A Lopez; Manuel A Barbieri
Journal:  Eur J Pharmacol       Date:  2011-09-19       Impact factor: 4.432

2.  Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive alpha-methylenebutyrolactone functions.

Authors:  A J Hay; M Hamburger; K Hostettmann; J R Hoult
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  Neurotoxicity of artemisinin analogs in vitro.

Authors:  D L Wesche; M A DeCoster; F C Tortella; T G Brewer
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 4.  Cynaropicrin: A Comprehensive Research Review and Therapeutic Potential As an Anti-Hepatitis C Virus Agent.

Authors:  Mahmoud F Elsebai; Andrei Mocan; Atanas G Atanasov
Journal:  Front Pharmacol       Date:  2016-12-08       Impact factor: 5.810

5.  Toxicity Assessment of Asteraceae Centaurea Repens L Extract in Mice.

Authors:  Mohammad Moradi; Faraz Mojab; Sepideh Arbabi Bidgoli
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

6.  A Potential Nutraceutical Candidate Lactucin Inhibits Adipogenesis through Downregulation of JAK2/STAT3 Signaling Pathway-Mediated Mitotic Clonal Expansion.

Authors:  Xin Wang; Min Liu; Guo He Cai; Yan Chen; Xiao Chen Shi; Cong Cong Zhang; Bo Xia; Bao Cai Xie; Huan Liu; Rui Xin Zhang; Jun Feng Lu; Meng Qing Zhu; Shi Zhen Yang; Xin Yi Chu; Dan Yang Zhang; Yong Liang Wang; Jiang Wei Wu
Journal:  Cells       Date:  2020-01-31       Impact factor: 6.600

7.  Phytochemical identification, acute and subchronic oral toxicity assessments of hydroalcoholic extract of Acroptilon repens in BALB/c mice: A toxicological and mechanistic study.

Authors:  Ayat Dashti; Mohammad Shokrzadeh; Mohammad Karami; Emran Habibi
Journal:  Heliyon       Date:  2022-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.